You didn't stall the rally, management did as usual. Personally, I sold out when it went over .14; now looking at it as objectively as possible. The company has a great story, exciting technology and huge potential. People seem to want to buy but the stock can only go so high without performance. So as I have said several times, the market gives the stock a value of .08 to .10 based on the Carpenter deal. After the delivery of the machine to MDA it tacked on another 8 cents on the excitement of the announcement and has now settled back to valuing the Flynn technology at .02 to .04 and we have a price in the .12 to .15 range.
The rally stalled and reversed because:
1. After 3 years of trying to land another metals contract, still nothing delivered.
2. After searching the CRS website, still no hits on mithralmax.
3. After a year of working for the company, still no signs of anything produced by Upham.
4. No clear stategy communicated for what happens after 6 months of testing by MDA - licensing deal? more dilution? more testing? go it alone or with a partner?
Overall a nice move from 4 cents back to the level of 4 years ago, but the stock can't continue to go up by itself. I will consider taking a new position if the price goes below .11 or if management performance merits a higher price.
News 
Market Data 
Discover 
